These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19119784)

  • 1. [Predicting liver fibrosis with non-invasive tests--a hope for the future].
    Marín Gabriel JC; Solís Herruzo JA
    Rev Esp Enferm Dig; 2008 Oct; 100(10):605-10. PubMed ID: 19119784
    [No Abstract]   [Full Text] [Related]  

  • 2. [Utility of various non-invasive methods for fibrosis prediction among Basque Country patients with phenotypic hemochromatosis].
    Castiella A; Zapata E; Otazua P; Fernández J; Alustiza JM; Ugarte M; Legasa L; Galardi A; Ugalde A; Barredo I; Arriola JA
    Rev Esp Enferm Dig; 2008 Oct; 100(10):611-4. PubMed ID: 19119785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imaging.
    Olynyk JK; St Pierre TG; Britton RS; Brunt EM; Bacon BR
    Am J Gastroenterol; 2005 Apr; 100(4):837-41. PubMed ID: 15784029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCV and C282Y: a sinister synergism?
    Russo M; Grimm IS
    Gastroenterology; 1999 Feb; 116(2):494-5. PubMed ID: 9922334
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-invasive assessment of liver fibrosis in C282Y homozygous HFE hemochromatosis.
    Legros L; Bardou-Jacquet E; Latournerie M; Guillygomarc'h A; Turlin B; Le Lan C; Désille Y; Lainé F; Moirand R; Brissot P; Deugnier Y; Guyader D
    Liver Int; 2015 Jun; 35(6):1731-8. PubMed ID: 25495562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients.
    Omran D; Zayed RA; Nabeel MM; Mobarak L; Zakaria Z; Farid A; Hassany M; Saif S; Mostafa M; Saad OK; Yosry A
    Viral Immunol; 2018 May; 31(4):315-320. PubMed ID: 29630460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation for fibrosis predicting index in hereditary hemochromatosis.
    Castiella A; Emparanza JI
    Am J Gastroenterol; 2005 Oct; 100(10):2366-7. PubMed ID: 16181396
    [No Abstract]   [Full Text] [Related]  

  • 8. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.
    Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A
    Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C.
    Stauber RE; Lackner C
    World J Gastroenterol; 2007 Aug; 13(32):4287-94. PubMed ID: 17708599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis.
    Crawford DH; Murphy TL; Ramm LE; Fletcher LM; Clouston AD; Anderson GJ; Subramaniam VN; Powell LW; Ramm GA
    Hepatology; 2009 Feb; 49(2):418-25. PubMed ID: 19177571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transient elastography (Fibroscan), a new non-invasive method to evaluate hepatic fibrosis].
    Mendoza J; Gómez-Domínguez E; Moreno-Otero R
    Med Clin (Barc); 2006 Feb; 126(6):220-2. PubMed ID: 16510096
    [No Abstract]   [Full Text] [Related]  

  • 12. Iron genes, dysmetabolism and fibrosis in chronic hepatitis C.
    Valenti L; Dongiovanni P; Fargion S; Fracanzani AL
    J Hepatol; 2008 Mar; 48(3):513-4; author reply 514-5. PubMed ID: 18194822
    [No Abstract]   [Full Text] [Related]  

  • 13. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
    Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of liver fibrosis in chronic viral hepatitis C infection using the Sabadell NIHCED (Non-Invasive Hepatitis-C-Related Cirrhosis Early Detection) index.
    Bejarano G; Vergara M; Dalmau B; Puig J; Bella MR; Suárez D; Calvet X
    Rev Esp Enferm Dig; 2009 May; 101(5):325-35. PubMed ID: 19527078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic iron, serum ferritin, HFE mutation, and hepatic fibrosis in chronic hepatitis C.
    Won JE; Jeong SH; Chung JI; Lee JH; Hwang SH; Kim JW; Lee SH; Kim N; Park YS; Lee DH; Kim H
    Intervirology; 2009; 52(5):239-46. PubMed ID: 19602897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive and non-invasive monitoring of hepatitis C virus-induced liver fibrosis: alternatives or complements?
    Olga OZ; Nikolai DY
    Curr Pharm Biotechnol; 2003 Jun; 4(3):195-209. PubMed ID: 12769763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive evaluation of liver fibrosis in chronic hepatitis C.
    Trifan A; Cojocariu C; Sfarti C; Singeap AM; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):135-8. PubMed ID: 23077885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticipate a cirrhosis without a hepatic biopsy in patients with hemochromatosis].
    Buffet C
    Presse Med; 2003 Jul; 32(24):1109-10. PubMed ID: 12947738
    [No Abstract]   [Full Text] [Related]  

  • 19. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
    Sebastiani G; Vario A; Guido M; Alberti A
    J Viral Hepat; 2008 Mar; 15(3):212-8. PubMed ID: 18179453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal hemochromatosis: failure of deferoxamine therapy.
    Jonas MM; Kaweblum YA; Fojaco R
    J Pediatr Gastroenterol Nutr; 1987; 6(6):984-8. PubMed ID: 3681586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.